1 / 32

Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin

Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin. Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD* Grant Ritter, PhD* Daniel Gilden,+ William Stason, MD,MS* Christine Bishop, PhD* *Brandeis University; +JEN Associates

Download Presentation

Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD* Grant Ritter, PhD* Daniel Gilden,+ William Stason, MD,MS* Christine Bishop, PhD* *Brandeis University; +JEN Associates Supported by the Centers for Medicare & Medicaid Services under Contract No. CMS 500-00-0031/T.O. #2 to Brandeis University AcademyHealth Annual Research Meeting, June 8-10, 2008

  2. Framework Better use of drugs and medical services Prescription coverage Less Medicaid entry Maintain health Lower nursing home use

  3. Past research • Rector (2004), Safran (2005), Leung (2005) – About 30% of low income people skip some prescribed medications • Soumerai et al. (1991) –Limiting drugs to vulnerable population increased nursing home admissions • Gilman (2004) – Members of Prescription Assistance Programs (PAP) skip fewer doses than comparable controls • Shepard (2006) – SeniorCare halved risk of skimping • Leung (2005) – Risk is related to individual characteristics

  4. In mid-2002, Illinois and Wisconsin initiated “SeniorCare” (SC) pharmacy assistance programs (PAPs) that provide low-income persons aged 65+ with publicly funded prescription drug assistance. Maximum co-payments per prescription are generally $4 in IL and $15 in WI. Enrollees with incomes up to 200% of the federal poverty limit (FPL) are funded under a Medicaid waiver designed to help seniors improve prescription drug use, maintain health and reduce financial vulnerability due to prescription costs. Program background

  5. 68,292 Wisconsin members, who were all new enrollees (1,189 interviewed), 121,000 Illinois members previously in Circuit Breaker, a limited PAP that excluded mental health and gastro-intestinal drugs and automatically rolled over into SC (termed ‘IL rollovers, 374 interviewed); 47,782 Illinois members not previously in this PAP (termed ‘IL new,’ 664 interviewed). Three strata studied

  6. Skimping by Income Group

  7. Study Design for Medicaid Analysis • Ohio served as the comparison state. • Using Medicare claims and zip codes, matched Illinois and Wisconsin enrollees exactly on demographic and disease categories to similar Ohio Medicare beneficiaries. • Used propensity scores to match closely on disease severity and socio-economic characteristics based on census information and Social Security benefits.

  8. Population Studied • Needed precise matching on income for examining Medicaid entry • Limited this analysis to buy-in Medicare beneficiaries in the three states • Received subsidies for Medicare premiums and deductibles • Qualified Medicare Beneficiaries, QMB • Special Low Income Medicare Beneficiaries, SLMB • We matched 7,699 Illinois and 1,798 Wisconsin buy-in beneficiaries to comparable buy-in Ohio controls.

  9. Research Objective:Evaluate First Year Impacts on • Nursing home entry • Medicaid entry • Medicaid expenditures

  10. Approach • Descriptive analysis • Multivariate analysis

  11. Nursing Home Entry among Wisconsin Buy-in Beneficiaries and Matched Ohio Controls

  12. Medicaid Entry amongWisconsin Buy-in Beneficiaries and Matched Ohio Controls

  13. Hazard Function for Nursing Home Entry, Wisconsin, part 1

  14. Hazard Function for Nursing Home Entry, Wisconsin, part 2

  15. Adjusted nursing home entry (SC/OH)

  16. Crude risk ratio forMedicaid entry (SC/OH)

  17. Relative spending per entrant (SC/OH)

  18. Relative spending per enrollee (SC/OH)

  19. Illinois summary • Due to preexisting PAP, SeniorCare did not reduce Medicaid entry, but did reduce nursing home entry and spending. • Cumulative rate of nursing home entry of Illinois SeniorCare buy-in beneficiaries (2.4%) was half the rate of the matched Ohio controls (4.4%). • Medicaid spending over the first year when averaged over all Illinois buy-in SeniorCare members (with standard errors of the mean) was $631 ($26) vs. $1,605 ($83) for matched buy-in Ohio controls • Per enrollee savings $974 ($87) or 61%. • Savings in Illinois did not quite equal the state’s share of first-year program costs per enrollee year ($1,394).

  20. Wisconsin summary • SeniorCare buy-in enrollees had half the rate Medicaid entry in the first year (11%) than matched Ohio controls (22%) • Wisconsin SC had half the rate of nursing home entry (2.2%) compared to Ohio controls (4.5%) • Had $1,190 ($163) or 81% lower Medicaid spending per buy-in enrollee. • Wisconsin savings on buy-ins were greater than the state’s share of first-year program costs per enrollee year ($1,032).

  21. Extrapolation possible? • Question: Do the data allow examining impacts on nursing home and Medicaid for all SeniorCare enrollees? • Answer: No • Why not? Ascertainment of income

  22. Medicaid entry by family income

  23. Approximate probability of Medicaid entry

  24. Household incomes by neighborhood

  25. Neighborhood: weak predictor of family income

  26. Unsuccessful extrapolation beyond buy-ins

  27. Conclusions • 50% reductions in skimping applied to all SeniorCare enrollees • Comparable declines in nursing home entry among buy-ins. • First year savings in buy-in population not quite enough to pay for the program costs in Illinois • These savings were more than sufficient in Wisconsin. • Prescription drug coverage for vulnerable populations pays off with less nursing home entry and lower costs.

  28. Limitations • Differences in nursing home and Medicaid policies among states could confound interpretation

  29. Strength: Consistent improvements in • Self reported behavior (skimping) • Costly services (nursing home entry) • Medicaid expenditures

  30. Research implications • Observations and natural experiments very powerful. • Must understand and control for selection effects. • Stay within the data.

  31. Policy implications • Enrollment of needy elders in both states benefited from outreach, straightforward design, and federal subsidies that extended to 200% of the FPL. • These findings show the value of completing “coverage” with access to prescription drugs.

  32. Thank you Shepard@brandeis.edu

More Related